You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Impedance Threshold Value for Improving Standard CPR

    SBC: ADVANCED CIRCULATORY SYSTEMS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Despite the widespread practice of basic and advanced life support, over 1000 patients die each day in the United States from an out-of-hospital cardiac arrest. Even though they receive standard cardiopulmonary resuscitation (sCPR) the average national survival to hospital discharge for these patients is less than 5%. The applicants have developed the inspir ...

    SBIR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health
  2. Development of a blood test for breast cancer detection

    SBC: INTEGRATED TECHNOLOGIES AND SRVCS INTRNTL            Topic: N/A

    DESCRIPTION (provided by applicant): Mammography is the benchmark for breast disease detection and diagnosis. However, it can miss 10-15% of early stage breast cancers, and it is unable to distinguish between benign and malignant lesions with certainty. Av ailability of an alternate method e.g. biomarker based, which allows early detection/precise distinction between benign disease and breast canc ...

    SBIR Phase I 2008 Department of Health and Human ServicesNational Institutes of Health
  3. A Wearable Device for Wireless Acquisition of High Density Surface EMG Signals

    SBC: ADVANCED MEDICAL ELECTRONICS CORP            Topic: N/A

    DESCRIPTION (provided by applicant): Advanced Medical Electronics seeks to develop a wearable device for the wireless acquisition of high-density surface-electromyogram (HD sEMG) signals. A new wireless networking standard called ultra-wideband (UWB) makes possible the creation of an ambulatory research HD sEMG instrument that can transmit 128 or more channels of data in real time. High-density s ...

    SBIR Phase I 2008 Department of Health and Human ServicesNational Institutes of Health
  4. Development of a Digital Sign System for Indoor Wayfinding by the Visually Impair

    SBC: ADVANCED MEDICAL ELECTRONICS CORP            Topic: N/A

    DESCRIPTION (provided by applicant): It is challenging for visually-impaired people to find their way in unfamiliar, complex indoor spaces such as schools or office buildings. GPS technology has already been exploited for speech-based navigation for visual ly-impaired wayfinding in outdoor environments, but there is no equivalent technology for indoor wayfinding. Sighted pedestrians may sometimes ...

    SBIR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health
  5. Hearing Aid Connectivity to Consumer Electronics

    SBC: ADVANCED MEDICAL ELECTRONICS CORP            Topic: N/A

    DESCRIPTION (provided by applicant): This project will apply novel ultra-wideband (UWB) wireless impulse radio technology to provide connectivity from consumer electronics devices directly to micro- behind-the-ear (micro-BTE) hearing aids. In hearing aids, capturing sound close to the source before it is combined with background noise offers better signal to noise ratio. In the case of consumer e ...

    SBIR Phase I 2008 Department of Health and Human ServicesNational Institutes of Health
  6. Profiling ER, PR, EGFR and HER2 in Breast Cancer Using Multiplex Tissue Immusta

    SBC: 20 20 Genesystems Inc            Topic: N/A

    DESCRIPTION (provided by applicant): We propose to develop a novel method and kit for profiling the expression and activation of signal transduction proteins in breast tumors. The goal is to create new companion diagnostics to better select patients like ly to respond to targeted therapies, including Herceptin. and novel tyrosine kinase inhibitors. 20/20 will utilize its proprietary Layered Expr ...

    SBIR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health
  7. Inhaled nisin as an emergency intervention against antibiotic sensitive or resist

    SBC: AFG BIOSOLUTIONS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The deliberate release of Bacillus anthracis spores remains an imminent threat both in terms of bioterrorism and biowarfare. Individuals who inhale these spores are at extreme risk of infection and death from anthrax. C urrent prophylaxis and therapy in the event of B. anthracis spore inhalation fall into two categories. Vaccination to protect against future ex ...

    SBIR Phase I 2008 Department of Health and Human ServicesNational Institutes of Health
  8. Add-on module for ONCAD for diagnosing infiltrating lobular carcinoma

    SBC: Alan Penn & Associates Inc            Topic: N/A

    DESCRIPTION (provided by applicant): The specific aim of this study is to develop an add-on module for the ONCAD breast MRI CAD system that will provide radiologists with additional assistance when they have suspicion of the presence of infiltrating lobula r carcinoma (ILC). The proposed research will investigate the possibility of developing, training and evaluating an ILC- specific algorithm tha ...

    SBIR Phase I 2008 Department of Health and Human ServicesNational Institutes of Health
  9. Generation of a Modified DT_IL3 Fusion Toxin

    SBC: ANJIN GROUP, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): A number of protein fusion toxins, composed of the diphtheria toxin (DT) toxophore and a targeting ligand, have been assembled and tested in Phase I clinical trials for the treatment of leukemias. To date, the only FDA approved protein fusion toxin is ONTAK. ONTAK is a DT, interleukin-2 receptor-targeted fusion toxin used to treat persistent or recurrent, cuta ...

    SBIR Phase I 2008 Department of Health and Human ServicesNational Institutes of Health
  10. Further Analysis of a VLS Modified IL-2 Receptor Targeted Toxin

    SBC: ANJIN GROUP, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The project seeks to further the development of a series of diphtheria toxin mutants which, when employed in the construction of protein fusion toxins, display reduced induction of leakage through vascular endothelial c ell monolayers. The goals of this Phase I proposal are to evaluate two, in vivo models of vascular leakage, selecting one model for further in ...

    SBIR Phase I 2008 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government